Results 121 to 130 of about 23,517 (220)

Association of QRS Notch Resolution During LV‐Only Fusion Pacing With Early Left Ventricular Reverse Remodeling After Cardiac Resynchronization Therapy

Journal of Arrhythmia, Volume 42, Issue 4, August 2026.
QRS notch/slur resolution during LV‐only fusion pacing, combined with an LV‐only pacing percentage ≥ 50% at 1 month, was independently associated with early left ventricular reverse remodeling and may help guide post‐implant CRT optimization. ABSTRACT Background Cardiac resynchronization therapy (CRT) improves outcomes in patients with heart failure ...
Junji Morita, Yuhei Kasai, Yumetsugu Munakata, Takayuki Kitai, Kei Murakami, Kazunari Mitsuishi, Daisuke Hachinohe, Yusuke Kondo   +7 more
wiley   +1 more source

Cannon ‘A' waves during complete atrioventricular block

Türk Kardiyoloji Derneği Arşivi, 2016
Luis Álvarez - Acosta, Alejandro Quijada - Fumero, Raquel Pimienta - Gónzalez, Julio S. Hernández - Afonso   +3 more
doaj   +1 more source

Reversible Complete Atrioventricular Block Due to Rupture of the Left Coronary Aortic Sinus. [PDF]

JACC Case Rep
Kawase K, Nakajima K, Miyazaki Y, Mori S, Masuda T, Horinouchi H, Kitai T, Fukuda T, Kusano K.   +8 more
europepmc   +1 more source

Cardioneuroablation for carotid sinus syndrome mediated by complete atrioventricular block. [PDF]

J Arrhythm, 2023
Baskovski E, Ates B, Ates B, Altin T, Akyurek O.   +4 more
europepmc   +1 more source

A novel selective stabilizer of the ryanodine receptor 2 prevents stress‐induced ventricular arrhythmias without impairing cardiac function

British Journal of Pharmacology, Volume 183, Issue 15, Page 4321-4343, August 2026.
Abstract Background and Purpose Aberrant activation of type 2 ryanodine receptors (RyR2) causes lethal arrhythmias, such as catecholaminergic polymorphic ventricular tachycardia (CPVT). Developing drugs that suppress RyR2 hyperactivation may be key to novel arrhythmia treatments.
Nagomi Kurebayashi, Masami Kodama, Hana Inoue, Masato Konishi, Masami Sugihara, Takashi Murayama, Ryosuke Ishida, Koichiro Ishii, Shuichi Mori, Yukari Endo, Xi Zeng, Yukiko U. Inoue, Takayoshi Inoue, Satoru Noguchi, Hajime Nishio, Eri Nakashima, Norio Suzuki, Noriko Nakaya, Ryushi Sato, Yuya Otori, Ayuna Tsutsumi, Mirei Takahashi, Takayuki Oka, Haruo Ogawa, Kayoko Kanamitsu, Hiroyuki Kusuhara, Utako Yokoyama, Junko Kurokawa, Hiroyuki Kagechika, Takashi Sakurai   +29 more
wiley   +1 more source

Complete Atrioventricular Block Due to Severe Hyperkalemia in a Hemodialysis Patient: Successful Management with Temporary Transvenous Pacing. [PDF]

Int Med Case Rep J
Abdi AE, Arın CB, Abdi IA, Ahmed SA, Dahir OF, Aden AS, Hassan MO.   +6 more
europepmc   +1 more source

Pregnancy and complete atrioventricular block: a case report. [PDF]

Ann Med Surg (Lond), 2023
López B, Batallanos M.
europepmc   +1 more source

Diltiazem N‐oxide, a novel ischaemia‐activated prodrug, prevents ischaemia‐induced ventricular fibrillation without off‐target adverse effects

British Journal of Pharmacology, Volume 183, Issue 16, Page 4646-4662, August 2026.
Abstract Background and Purpose Ventricular fibrillation (VF) in coronary heart disease accounts for up to 70% of sudden cardiac death. We examined whether diltiazem N‐oxide (DNO) has ischaemia‐selective antiarrhythmic activity. Experimental Approach Randomised and blinded experiments were performed in rat isolated hearts and in anaesthetised rats to ...
Louise M. Hesketh, Gabriel A. Watson, Francesca Mazzacuva, Zoe Hoare, Thomas R. Eykyn, Michael J. Curtis   +5 more
wiley   +1 more source

Anesthetic management of a cesarean section in a pregnant patient with congenital complete atrioventricular block without pacemaker - A case report. [PDF]

Saudi J Anaesth
Silva JT, Abrantes CS, Mendes Â, Machado H.   +3 more
europepmc   +1 more source

Acute Myocarditis: From Pathophysiology to Risk‐Stratified Management—A Clinical Review

European Journal of Clinical Investigation, Volume 56, Issue 8, August 2026.
Stepwise approach to patients with suspected acute myocarditis, integrating the 2024 American College of Cardiology (ACC) four‐stage classification (Stages A–D) and the 2025 European Society of Cardiology (ESC) inflammatory myopericardial syndrome (IMPS) framework. Step 1 (Initial Assessment): clinical presentation, first‐line investigations (ECG, high‐
Michele Golino, Marco Giuseppe Del Buono, Michele Marchetta, Nicola Potere, Aldo Bonaventura, Alessandra Vecchiè, Danilo Malandrino, Giacomo Emmi, Jordana Kron, Antonio Abbate   +9 more
wiley   +1 more source